Barclays
DOC icon

Barclays’s Healthpeak Properties DOC Stock Holding History

Barclays’s Portfolio DOC Stock Details DOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,800
Closed -$349K – 6431
2019
Q3 		$349K Sell
9,800
-5,500
-36% -$186K ﹤0.01% 4537
2019
Q2 		$489K Buy
15,300
+12,500
+446% +$389K ﹤0.01% 4342
2019
Q1 		$88K Sell
2,800
-24,700
-90% -$752K ﹤0.01% 5460
2018
Q4 		$768K Buy
27,500
+5,500
+25% +$152K ﹤0.01% 3391
2018
Q3 		$579K Sell
22,000
-13,000
-37% -$342K ﹤0.01% 4144
2018
Q2 		$904K Buy
35,000
+1,500
+4% +$35.4K ﹤0.01% 3393
2018
Q1 		$778K Sell
33,500
-1,700
-5% -$39.5K ﹤0.01% 3511
2017
Q4 		$918K Sell
35,200
-19,100
-35% -$506K ﹤0.01% 3206
2017
Q3 		$1.51M Buy
54,300
+19,200
+55% +$577K ﹤0.01% 2613
2017
Q2 		$1.12M Buy
35,100
+1,800
+5% +$57.1K ﹤0.01% 2771
2017
Q1 		$1.04M Buy
33,300
+9,500
+40% +$292K ﹤0.01% 2700
2016
Q4 		$707K Buy
23,800
+12,930
+119% +$394K ﹤0.01% 3075
2016
Q3 		$376K Sell
10,870
-17,129
-61% -$599K ﹤0.01% 3461
2016
Q2 		$902K Buy
27,999
+8,455
+43% +$263K ﹤0.01% 2708
2016
Q1 		$570K Buy
19,544
+11,309
+137% +$339K ﹤0.01% 3043
2015
Q4 		$285K Sell
8,235
-21,191
-72% -$709K ﹤0.01% 3624
2015
Q3 		$992K Buy
29,426
+24,485
+496% +$847K ﹤0.01% 2720
2015
Q2 		$162K Sell
4,941
-8,564
-63% -$312K ﹤0.01% 4296
2015
Q1 		$529K Buy
13,505
+3,952
+41% +$159K ﹤0.01% 3575
2014
Q4 		$383K Sell
9,553
-1,207
-11% -$47.9K ﹤0.01% 4119
2014
Q3 		$383K Sell
10,760
-175,131
-94% -$6.64M ﹤0.01% 4194
2014
Q2 		$6.94M Sell
185,891
-16,361
-8% -$616K 0.01% 1446
2014
Q1 		$7M Buy
202,252
+180,402
+826% +$6.23M 0.01% 1439
2013
Q4 		$717K Sell
21,850
-49,740
-69% -$1.77M ﹤0.01% 3735
2013
Q3 		$2.61M Buy
71,590
+46,556
+186% +$1.82M ﹤0.01% 2287
2013
Q2 		$1.04M Buy
+25,034
New +$1.14M ﹤0.01% 3306

Other funds holding DOC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Barclays's DOC Position: Q3 2026 in Review

Barclays increased its Healthpeak Properties (DOC) stake by 94% in Q3 2026, buying an estimated $15.4M and bringing the position to 1,493,282 shares worth $29.8M. The position accounts for 0.01% of the portfolio, ranked #1029.

Barclays first reported a position in DOC in Q2 2013 and has held it in 45 quarters since. The position peaked at $122M in Q4 2013. 647 funds tracked by Wall St. Rank hold DOC as of Q3 2026.

  • Barclays held 1,493,282 shares of Healthpeak Properties worth $29.8M as of Q3 2026.
  • Barclays bought 723,853 Healthpeak Properties shares in Q3 2026, an estimated $15.4M.
  • Healthpeak Properties made up 0.01% of Barclays's portfolio in Q3 2026, its #1029 holding.
  • Barclays first reported a position in Healthpeak Properties in Q2 2013 and has held it in 45 quarters since.
  • Barclays's Healthpeak Properties position peaked at $122M in Q4 2013.
  • 647 funds tracked by Wall St. Rank held Healthpeak Properties as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.